mortality/aging
• less than 10% of mice survive to P57, with the greatest mortality seen during the first 2 weeks of life
• neonatal treatment with an adeno-associated viral gene therapy expressing human MMUT (AAV-MMUT) rescues survival
|
• more than half of homozygous mice die during the first 2 weeks of life
• treatment at birth with an adeno-associated viral gene therapy expressing human MMUT (AAV-MMUT) results in survival of most pups
|
growth/size/body
• mice that survive beyond weaning weigh 50% less than controls
|
• mice that survive beyond weaning are severely growth impaired, with weights that are 50% less than in controls
• neonatal treatment with AAV-MMUT corrects growth
|
homeostasis/metabolism
• plasma methylmalonic acid concentrations are massively elevated
• neonatal treatment with AAV-MMUT reduces methylmalonic acid concentrations
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | DOID:0060740 |
OMIM:251000 |
J:332892 |